{"id":"FED-184","kind":"order","level":"federal","jurisdiction":"United States","state":"","metro":"","industry":"","agency":"","eco":"","issuer":"Secretary of Health and Human Services","authority":"FD\u0026C Act § 564","instrument":"Emergency Use Authorization Declaration: drugs and biological products","title":"Emergency Use Authorization Declaration, 85 Fed. Reg. 18250 (Apr. 1, 2020)","dateIssued":"2020-03-27","effective":"2020-03-27","end":"through the § 564 emergency","startDate":"2020-03-27","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["EMER","HC"],"addressees":["FDA; drug and biologic manufacturers (the basis of the vaccine EUAs, FED-185 to FED-187)"],"clause":"On March 27, 2020, on the basis of my determination of a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad and that involves the novel (new) coronavirus, I declared that circumstances exist justifying the authorization of emergency use of drugs and biological products during the COVID-19 pandemic","enforcement":"Framework","functions":["context: legal basis of every COVID-19 vaccine and therapeutic EUA"],"notes":"CONTEXT ONLY.","sourceUrl":"https://www.govinfo.gov/content/pkg/FR-2020-04-01/pdf/2020-06905.pdf","snapshot":"","fileExists":true,"fileBytes":178407,"grade":"primary","character":"","description":"","collection":"FED-A","url":"/library/FED-184","exhibitUrl":"/exhibit/FED-184","citation":"Secretary of Health and Human Services, Emergency Use Authorization Declaration: drugs and biological products (Mar. 27, 2020) (Ex. FED-184)","stateName":"","related":["FED-181","FED-074","FED-183","FED-182","FED-180"]}